AMENDR Trademark

Trademark Overview

On Friday, August 5, 2016, a trademark application was filed for AMENDR with the United States Patent and Trademark Office. The USPTO has given the AMENDR trademark a serial number of 87128774. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 30, 2019. This trademark is owned by Homology Medicines, Inc.. The AMENDR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services
amendr

General Information

Serial Number87128774
Word MarkAMENDR
Filing DateFriday, August 5, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 30, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2017

Trademark Statements

Goods and ServicesPharmaceutical research and development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHomology Medicines, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedford, MA 01730
Party NameHomology Medicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, September 30, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 30, 2019ABANDONMENT - NO USE STATEMENT FILED
Saturday, February 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 14, 2019EXTENSION 4 GRANTED
Thursday, February 14, 2019EXTENSION 4 FILED
Thursday, February 14, 2019TEAS EXTENSION RECEIVED
Monday, December 10, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, December 10, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 30, 2018EXTENSION 3 GRANTED
Monday, July 30, 2018EXTENSION 3 FILED
Monday, July 30, 2018TEAS EXTENSION RECEIVED
Wednesday, December 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 18, 2017EXTENSION 2 GRANTED
Monday, December 18, 2017EXTENSION 2 FILED
Monday, December 18, 2017TEAS EXTENSION RECEIVED
Thursday, June 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 20, 2017EXTENSION 1 GRANTED
Tuesday, June 20, 2017EXTENSION 1 FILED
Tuesday, June 20, 2017TEAS EXTENSION RECEIVED
Tuesday, February 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, December 14, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 23, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 16, 2016ASSIGNED TO EXAMINER
Tuesday, August 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 9, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

amendr services development research pharmaceutical